The Association of Serum Circulating Neuropeptide Q and Chemerin Levels with Cardiometabolic Risk Factors among Patients with Metabolic Syndrome
Marta Pelczyńska(Poznan University of Medical Sciences), Teresa Grzelak(Poznan University of Medical Sciences), Krystyna Czyżewska(Poznan University of Medical Sciences), Aniceta Ada Mikulska(Poznan University of Medical Sciences), Paweł Bogdański(Poznan University of Medical Sciences)
Cited by 5
Related Papers
The Role of Magnesium in the Pathogenesis of Metabolic Disorders
|Nutrients|2022|122
The Effect of Artificial Sweeteners Use on Sweet Taste Perception and Weight Loss Efficacy: A Review
|Nutrients|2022|100
Concentrations of omentin and vaspin versus insulin resistance in obese individuals
|Biomedicine & Pharmacotherapy|2016|41